{
  "id": "5a9e2386de7cb99d40000004",
  "type": "factoid",
  "question": "What is the drug forxiga used for?",
  "ideal_answer": "Dapagliflozin (Forxiga\u00ae) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) inhibitors and is used in the treatment of patients with type 2 diabetes.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/23170914",
    "http://www.ncbi.nlm.nih.gov/pubmed/28383856",
    "http://www.ncbi.nlm.nih.gov/pubmed/24030968",
    "http://www.ncbi.nlm.nih.gov/pubmed/25389049",
    "http://www.ncbi.nlm.nih.gov/pubmed/25402624",
    "http://www.ncbi.nlm.nih.gov/pubmed/25418019"
  ],
  "snippets": [
    {
      "text": "Dapagliflozin (forxiga\u00ae) : SGLT 2 cotransporter inhibitor as glucose-lowering agent in type 2 diabetes",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383856",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Dapagliflozin (DAPA) (Farxiga or Forxiga) is a sodium glucose cotransporter 2 (SGLT2) inhibitor approved for type 2 diabetes mellitus(T2DM) treatment.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25418019",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dapagliflozin (Forxiga) belongs to a new class of oral glucose-lowering drugs that inhibit renal glucose reabsorption and promote glycosuria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24030968",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Dapagliflozin (Forxiga\u00ae) is the first in a novel class of glucose-lowering agents known as sodium-glucose co-transporter-2 (SGLT2) inhibitors and is used in the treatment of patients with type 2 diabetes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23170914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "antidiabetic drug Forxiga (dapagliflozin)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25402624",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Treatment of patients with type 2 diabetes."
}